Shikonin selectively induces apoptosis in human prostate cancer cells through the endoplasmic reticulum stress and mitochondrial apoptotic pathway
Biochemistry, medical
Male
Membrane Potential, Mitochondrial
0303 health sciences
Endocrinology, Diabetes and Metabolism
Research
Clinical Biochemistry
Prostatic Neoplasms
Antineoplastic Agents
Apoptosis
Cell Biology
Endoplasmic Reticulum Stress
Mitochondria
3. Good health
03 medical and health sciences
Cell Line, Tumor
Humans
Pharmacology (medical)
Molecular Biology
Cell Proliferation
Naphthoquinones
DOI:
10.1186/s12929-015-0127-1
Publication Date:
2015-04-02T14:23:50Z
AUTHORS (7)
ABSTRACT
Despite the recent progress in screening and therapy, a majority of prostate cancer cases eventually attain hormone refractory chemo-resistant attributes. Conventional chemotherapeutic strategies are effective at very high doses for only palliative management these cancers. Therefore chemo-sensitization cells could be promising strategy increasing efficacy conventional agents patients. Recent studies have indicated that chemo-preventive natural restore pro-apoptotic protein expression induce endoplasmic reticulum stress (ER stress) leading to inhibition cellular proliferation activation mitochondrial apoptosis cells. reprogramming ER stress-mitochondrial dependent potential approach chemoresistant We aimed study effects naphthoquinone Shikonin human The results induces through dual induction dysfunction. induced ROS generation activated calpain activity. Moreover, addition antioxidants attenuated effects. also apoptotic pathway mediated enhanced Bax Bcl-2, disruption membrane (MMP) followed by caspase-9, caspase-3, PARP cleavage. suggest shikonin useful therapeutic cancers due its modulation pathways.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (47)
CITATIONS (55)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....